These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7860480)

  • 1. Chemotherapy induced refractory anaemia with ring sideroblasts in carcinoma breast.
    Dhot PS; Sharma MC; Kumar L; Saxena R
    J Assoc Physicians India; 1994 Feb; 42(2):153-4. PubMed ID: 7860480
    [No Abstract]   [Full Text] [Related]  

  • 2. Muehrcke's lines on nails after cyclophosphamide/adriamycin/fluorouracil.
    Gül U; Kiliç A
    Ann Pharmacother; 2004 Jun; 38(6):1089-90. PubMed ID: 15122002
    [No Abstract]   [Full Text] [Related]  

  • 3. Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancer.
    Mortimer J; Livingston RB; Hardesty IJ; Groppe CW; Purvis JD; Gupta M; Flournoy N
    Cancer Treat Rep; 1984; 68(7-8):1017-8. PubMed ID: 6744334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of adjuvant chemotherapy in breast carcinoma with a combination of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and AC (doxorubicin, cyclophosphamide). Initial results of a national cooperative study].
    Pribylová O; Petruzelka L; Honová H; Fischer J; Bustová I; Siffnerová H; Kůta M; Miller V; Hacklová M; Machácek J; Kohoutek M; Vodvárka P; Kyselá T; Tajblová J; Suk J; Dorazilová V; Bauer J
    Sb Lek; 1998; 99(1):25-31. PubMed ID: 9748796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Leukemia in patients with breast carcinoma after adjuvant chemotherapy and/or postoperative radiotherapy].
    Sack H
    Strahlenther Onkol; 1995 Jul; 171(7):420-1. PubMed ID: 7631268
    [No Abstract]   [Full Text] [Related]  

  • 7. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Persistent granulocytosis and hyperuricemia after a single G-CSF injection (Filgrastim) in treatment of chemotherapy-induced myelosuppression in metastatic breast carcinoma].
    Hofmann M; Mahlke M; Casper F; Brockerhoff P
    Zentralbl Gynakol; 1995; 117(6):314-6. PubMed ID: 7544054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Platelet aggregation during adjuvant chemotherapy with CMF].
    Sbalzarini G; Pandolfi C; Labadini A
    Minerva Med; 1991 Jun; 82(6):367-70. PubMed ID: 1648685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radiotherapy of carcinoma of the breast].
    Sinistrero G; Zola P; Sussio M; Giurgola L; Lio V
    Minerva Ginecol; 1985 Jun; 37(6):275-80. PubMed ID: 3839915
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient.
    Porta C; Casagranda I; Semino G; Moroni M; Ratto C
    Haematologica; 1993; 78(1):56-7. PubMed ID: 8387943
    [No Abstract]   [Full Text] [Related]  

  • 12. Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy.
    Gianni L; Baselga J; Eiermann W; Guillem Porta V; Semiglazov V; Lluch A; Zambetti M; Sabadell D; Raab G; Llombart Cussac A; Bozhok A; Martinez-Agulló A; Greco M; Byakhov M; Lopez Lopez JJ; Mansutti M; Valagussa P; Bonadonna G;
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8715-21. PubMed ID: 16361558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
    Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
    Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy and concomitant irradiation in inflammatory breast cancer.
    Tubiana-Mathieu N; Lejeune C; Bonnier P; Genet D; Adjadj DJ; Berda JF; Muracciole X; Delaby F; Clavere P; Benyoub A; Rhein B; Juin B; Piana L
    Anticancer Res; 2001; 21(4B):3061-7. PubMed ID: 11712811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of chemotherapy preceding exclusive conservative loco-regional radiotherapy in breast cancer].
    Baillet F; Housset M; Khayat D; Rozec C; Ucla L; Maulard C; Brunel P; Hu BQ; Delanian S
    Pathol Biol (Paris); 1992 Nov; 39(9):933-4. PubMed ID: 1538940
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.
    Bellon JR; Come SE; Gelman RS; Henderson IC; Shulman LN; Silver BJ; Harris JR; Recht A
    J Clin Oncol; 2005 Mar; 23(9):1934-40. PubMed ID: 15774786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary effects of adjuvant therapy].
    Giai M; De Fabiani E; Lamberto A; Cortese P; Giardina G
    Minerva Ginecol; 1985 Jun; 37(6):319-28. PubMed ID: 3162112
    [No Abstract]   [Full Text] [Related]  

  • 18. In regards to Arcangeli et al. (Int J Radiat Oncol Biol Phys 2006;64:161-167).
    Munshi A; Jalali R; Budrukar A
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):632; author reply 632-3. PubMed ID: 16690446
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant chemotherapy in breast cancer: back to the future.
    Colleoni M; Goldhirsch A
    Onkologie; 2003 Apr; 26(2):111-2. PubMed ID: 12771517
    [No Abstract]   [Full Text] [Related]  

  • 20. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
    Dubsky P; Sevelda P; Jakesz R; Hausmaninger H; Samonigg H; Seifert M; Denison U; Mlineritsch B; Steger G; Kwasny W; Stöger H; Bartsch R; Stierer M; Taucher S; Fridrik M; Schippinger W; Greil R; Pötter R; Gnant M;
    Clin Cancer Res; 2008 Apr; 14(7):2082-7. PubMed ID: 18381948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.